BRIEF published on 03/14/2025 at 07:35, 1 year 7 months ago Sensorion : Bilan 2024 et Perspectives pour 2025 Résultats Financiers Investissements Thérapies Géniques SENS-401 SENS-501
BRIEF published on 03/14/2025 at 07:35, 1 year 7 months ago Sensorion: 2024 Review and Outlook for 2025 Financial Results Investments SENS-401 SENS-501 Gene Therapies
PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 7 months ago Informations privilégiées / Communiqué sur comptes, résultats Sensorion présente ses résultats financiers pour l’exercice 2024, fait le point sur ses activités et annonce la mise à disposition du rapport annuel. Renforcement financier, essais cliniques avancés Résultats Financiers Innovation Scientifique Thérapie Génique Études Cliniques Sensorion
PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 7 months ago Inside Information / News release on accounts, results Sensorion reports full-year 2024 results and provides corporate update with significant milestones achieved in gene therapy clinical trials and financial highlights. Company well positioned for growth in 2025 Clinical Trials Financial Highlights Gene Therapy Full-year Results Sensorion
BRIEF published on 03/07/2025 at 07:35, 1 year 7 months ago Sensorion conclut le recrutement pour l'essai NOTOXIS sur le SENS-401 Essai Clinique Sensorion SENS-401 Cisplatine Ototoxicité
BRIEF published on 03/07/2025 at 07:35, 1 year 7 months ago Sensorion Completes Recruitment for NOTOXIS Trial of SENS-401 Clinical Trial Sensorion SENS-401 Cisplatin Ototoxicity
PRESS RELEASE published on 03/07/2025 at 07:30, 1 year 7 months ago Informations privilégiées / Autres communiqués Sensorion annonce la fin du recrutement des patients dans NOTOXIS, essai clinique Phase 2a SENS-401 pour prévenir ototoxicité cisplatine. Résultats NOTOXIS attendus fin 2025 Phase 2a Sensorion SENS-401 Ototoxicité NOTOXIS
PRESS RELEASE published on 03/07/2025 at 07:30, 1 year 7 months ago Inside Information / Other news releases Sensorion completes patient enrollment in NOTOXIS Phase 2a Clinical Trial of SENS-401 for Cisplatin-Induced Ototoxicity prevention, targeting a significant unmet medical need Clinical Trial Sensorion SENS-401 NOTOXIS Cisplatin-Induced Ototoxicity
BRIEF published on 02/21/2025 at 07:35, 1 year 8 months ago Sensorion's SENS-501 Clinical Trial Progresses with Positive DMC Recommendation Gene Therapy Clinical Trial Sensorion Hearing Loss SENS-501
BRIEF published on 02/21/2025 at 07:35, 1 year 8 months ago L'essai clinique SENS-501 de Sensorion progresse avec une recommandation DMC positive Essai Clinique Thérapie Génique Sensorion Perte Auditive SENS-501
Published on 10/26/2026 at 23:00, 12 minutes ago American Hotel Income Properties REIT LP to Host Third Quarter 2026 Results Conference Call on November 16, 2026
Published on 10/26/2026 at 22:00, 1 hour 12 minutes ago IBC Advanced Alloys Announces Issuance of Share-Based Compensation to Directors
Published on 10/26/2026 at 22:00, 1 hour 12 minutes ago Alset AI Announces Non-Brokered Private Placement Offering of a Minimum of $650,000 and a Maximum of $800,000
Published on 10/26/2026 at 21:30, 1 hour 42 minutes ago Clean Air Metals Announces Auditor Review of Q2 Financial Statements
Published on 10/26/2026 at 22:23, 49 minutes ago EQS-Adhoc: SMAG Mobile Antenna Masts AG: Changes to the Management Board
Published on 10/26/2026 at 21:57, 1 hour 14 minutes ago EQS-Adhoc: PAUL Tech AG: Noteholders’ Meeting in respect of the EUR 35 million notes resolves on extension of the term of the notes
Published on 10/26/2026 at 21:32, 1 hour 39 minutes ago UPDATE ON STRATEGIC TRANSACTION, FURTHER PORTFOLIO DISPOSAL PROCESS AND CONTINUED LENDER SUPPORT
Published on 10/26/2026 at 20:00, 3 hours 11 minutes ago EQS-Adhoc: Hypoport SE: Gross profit growth and increase in EBIT in Q1-Q3 2026
Published on 10/26/2026 at 19:10, 4 hours 2 minutes ago PolyPeptide announces results of the extraordinary general meeting of shareholders
Published on 10/26/2026 at 18:11, 5 hours 1 minute ago Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 18:11, 5 hours 1 minute ago Déclaration des transactions sur actions propres réalisées du 19/10/2026 au 25/10/2026
Published on 10/26/2026 at 17:45, 5 hours 27 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 10/26/2026 at 17:45, 5 hours 27 minutes ago Infotel : Déclaration des transactions sur actions propres réalisées du 19 au 23 octobre 2026 dans le cadre du programme de rachat d’actions.
